|
|
Volumn 43, Issue 2, 2006, Pages 57-60
|
|
Effectiveness and safety of insulin glargine in the therapy of complicated or secondary diabetes: Clinical audit
a
|
|
Author keywords
Cancer; Clinical audit; Effectiveness; Glargine; Insulin; Secondary diabetes; Type 2 diabetes mellitus
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CORTICOSTEROID;
GLUCOSE;
HEMOGLOBIN A1C;
INSULIN GLARGINE;
ORAL ANTIDIABETIC AGENT;
ADULT;
AGE DISTRIBUTION;
AGED;
ARTICLE;
CLINICAL ARTICLE;
COMORBIDITY;
CONTROLLED STUDY;
DIET RESTRICTION;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG COST;
DRUG DOSE REGIMEN;
DRUG EFFECT;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
FEMALE;
GLUCOSE BLOOD LEVEL;
HEMOGLOBIN DETERMINATION;
HUMAN;
HYPERPHAGIA;
HYPOGLYCEMIA;
INSULIN TREATMENT;
MALE;
MEDICAL AUDIT;
MEDICAL RECORD REVIEW;
METASTASIS;
NAUSEA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
SEX RATIO;
TREATMENT OUTCOME;
ADRENAL CORTEX HORMONES;
AGED;
ANTINEOPLASTIC AGENTS;
BLOOD GLUCOSE;
BODY MASS INDEX;
BODY WEIGHT;
CARDIOVASCULAR DISEASES;
COMORBIDITY;
DIABETES COMPLICATIONS;
DIABETES MELLITUS, TYPE 2;
DIABETIC RETINOPATHY;
DRUG ADMINISTRATION SCHEDULE;
FASTING;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
INSULIN;
KIDNEY FAILURE;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASMS;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
|
EID: 33746417198
PISSN: 09405429
EISSN: 14325233
Source Type: Journal
DOI: 10.1007/s00592-006-0213-7 Document Type: Article |
|
Times cited : (9)
|
|
References (5)
|
